Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
DiaMedica Therapeutics Inc. - Common Stock
(NQ:
DMAC
)
8.780
+0.150 (+1.74%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
240,764
Open
8.660
Bid (Size)
8.780 (2,700)
Ask (Size)
9.100 (900)
Prev. Close
8.630
Today's Range
8.613 - 8.960
52wk Range
3.190 - 9.230
Shares Outstanding
37,953,711
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's After-Market Session
↗
November 14, 2025
Via
Benzinga
DiaMedica Therapeutics Inc (NASDAQ:DMAC) Reports Q3 2025 Earnings and Clinical Progress
↗
November 12, 2025
DiaMedica reports Q3 2025 results, advancing DM199 for stroke and preeclampsia. The company has a cash runway into H2 2027 to fund clinical trials.
Via
Chartmill
Performance
YTD
+59.3%
+59.3%
1 Month
+48.3%
+48.3%
3 Month
+22.6%
+22.6%
6 Month
+115.2%
+115.2%
1 Year
+64.7%
+64.7%
More News
Read More
DiaMedica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
November 12, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
An Overview of DiaMedica Therapeutics's Earnings
↗
November 11, 2025
Via
Benzinga
Exploring DiaMedica Therapeutics's Earnings Expectations
↗
August 11, 2025
Via
Benzinga
DiaMedica Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
November 10, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update November 13, 2025
November 06, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 15, 2025
Via
Benzinga
DiaMedica Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
September 29, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences
September 05, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference
September 02, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 18, 2025
Via
Benzinga
DiaMedica Posts Narrower Loss in Q2
↗
August 12, 2025
Via
The Motley Fool
Topics
Intellectual Property
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Reports Q2 2025 Earnings: Narrower Loss and Promising Clinical Updates Drive Stock Surge
↗
August 12, 2025
Via
Chartmill
DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
August 12, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Earnings Scheduled For August 12, 2025
↗
August 12, 2025
Via
Benzinga
DiaMedica Therapeutics Appoints Julie Krop, MD, as Chief Medical Officer
August 06, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025
August 05, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement
July 23, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Raises $30 Million in Private Placement to Accelerate Industry Leading Preeclampsia and Fetal Growth Restriction Pipeline
July 21, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Reports Positive Interim Phase 2 Preeclampsia Results: Statistically Significant Reductions in Blood Pressure and No Placental Transfer
July 17, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
June 24, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics to Present at Jefferies Global Healthcare Conference 2025
May 22, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia
May 19, 2025
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Frequently Asked Questions
Is DiaMedica Therapeutics Inc. - Common Stock publicly traded?
Yes, DiaMedica Therapeutics Inc. - Common Stock is publicly traded.
What exchange does DiaMedica Therapeutics Inc. - Common Stock trade on?
DiaMedica Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DiaMedica Therapeutics Inc. - Common Stock?
The ticker symbol for DiaMedica Therapeutics Inc. - Common Stock is DMAC on the Nasdaq Stock Market
What is the current price of DiaMedica Therapeutics Inc. - Common Stock?
The current price of DiaMedica Therapeutics Inc. - Common Stock is 8.780
When was DiaMedica Therapeutics Inc. - Common Stock last traded?
The last trade of DiaMedica Therapeutics Inc. - Common Stock was at 12/05/25 04:00 PM ET
What is the market capitalization of DiaMedica Therapeutics Inc. - Common Stock?
The market capitalization of DiaMedica Therapeutics Inc. - Common Stock is 333.23M
How many shares of DiaMedica Therapeutics Inc. - Common Stock are outstanding?
DiaMedica Therapeutics Inc. - Common Stock has 333M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.